
The event will be part of the Sachs Spring Life Sciences Week (#SSLSW), which will also incorporate the 19th Annual European Life Sciences CEO Forum (#Sachs_ELSF), allowing relevant attendees to register for both events.
Building on the success of its previous editions in the USA, the European edition will provide a dedicated platform for corporate and financial investors, pharma executives, and advisors to engage with leading and emerging neuroscience companies. The forum will address drug and tech innovation in Europe and the latest global developments in CNS. For American companies attending, there is an opportunity to network with the large investor audience participating in both ENIF and ELSF.
The physical programme will feature panels and keynotes, which will be recorded and available on demand by the 12th of March. In addition, the event will feature pre-arranged in-person meetings, virtual partnering during the online week, and a networking reception, offering ample opportunities to engage with stakeholders across the neuroscience ecosystem.